Essential Hope for Multiple SclerosisAugust 23, 2004New research by psychologists reveals the positive effects of aromatherapy on the quality of life for Multiple Sclerosis (MS) sufferers. Researchers at the University of Teeside found MS patients, in spite of experiencing the same symptoms, felt more vitality, happiness and peace during aromatherapy treatment, and less depression, fatigue and anxiety. Their findings are presented today, Friday 10 September 2004, at the British Psychological Society's Division of Health Psychology Annual Conference, hosted by Queen Margaret University College and taking place at Pollock Halls in Edinburgh The authors say that the mechanism by which improvements in quality of life occurred is unknown, but that there is "growing evidence for the effectiveness of aromatherapy on chronic illness". MS is a chronic neurological condition that affects many people in the UK today, and has limited treatment options. This finding offers some hope that whilst a cure is sought for chronic illness, Health Psychology could help people to live with its effects in the long-term. British Psychological Society (BPS) | |||||||||||||||||||||
|
Related Multiple Sclerosis Current Events and Multiple Sclerosis News Articles Vitamin D deficiency in infants and nursing mothers carries long-term disease risks Once believed to be important only for bone health, vitamin D is now seen as having a critical function in maintaining the immune system throughout life. MRI scans can predict effects of MS flare-ups on optic nerve One of the most pernicious aspects of multiple sclerosis (MS) - its sheer unpredictability - may finally be starting to yield to advanced medical imaging techniques. Melatonin may save eyesight in inflammatory disease Current research suggests that melatonin therapy may help treat uveitis, a common inflammatory eye disease. The related report by Sande et al., "Therapeutic Effect of Melatonin in Experimental Uveitis," appears in the December issue of The American Journal of Pathology. Researcher tricks immune system in diabetic mice The body's immune system hates strangers. When its security patrol spots a foreign cell, it annihilates it. In the war against diseases, nerve cells need their armor In a new study, researchers at the Montreal Neurological Institute (MNI), McGill University, and the Université de Montréal have discovered an essential mechanism for the maintenance of the normal structure of myelin, the protective covering that insulates and supports nerve cells (neurons). Intraspinal implant of mesenchymal stem cells may not heal the demyelinated spinal cord Multiple sclerosis is a disease caused by the loss of the myelinated sheath surrounding the nerve fibers of the spinal cord. Multiple sclerosis research charges ahead with new mouse model of disease A new study highlights the role of a charge-switching enzyme in nervous system deficits characteristic of multiple sclerosis and other related neurological illness. Lung airway cells activate vitamin D and increase immune response Vitamin D is essential to good health but needs to be activated to function properly in the human body. Until recently, this activation was thought to happen primarily in the kidneys, but a new University of Iowa study finds that the activation step can also occur in lung airway cells. Type-1 diabetes not so much bad genes as good genes behaving badly, Stanford research shows Investigators combing the genome in the hope of finding genetic variants responsible for triggering early-onset diabetes may be looking in the wrong place, new research at the Stanford University School of Medicine suggests. Phase IIb data show that BG-12 significantly reduced brain lesions in multiple sclerosis Biogen Idec (NASDAQ: BIIB) today announced the publication of Phase IIb data showing that a 240 mg three-times-daily dose of the company's novel oral compound, BG-12 (BG00012, dimethyl fumarate), reduced the number of new gadolinium enhancing (Gd+) lesions by 69 percent in patients with relapsing-remitting multiple sclerosis (MS) when compared to treatment with placebo (p<0.0001). More Multiple Sclerosis Current Events and Multiple Sclerosis News Articles |
|||||||||||||||||||||
|
|||||||||||||||||||||
|
|||||||||||||||||||||